Dublin, Dec. 15, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.
This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine
The report provides current share of each segment: market size in 2015 and projected value for the years 2020 and 2025. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.
Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Biochip and Microarray Technologies
3. Microfluidics-based Biochips and Microarrays
4. Protein Biochips
5. Nanobiotechnology-based Biochips & Microarrays
6. Biochips & Microarrays for Epigenetics
7. Applications of Microarrays in Drug Discovery & Development
8. Biochips for Biomarkers, Molecular Diagnostics & Personalized
9. Markets
10. Companies
11. References
For more information about this report visit http://www.researchandmarkets.com/research/9rp3gn/biochips_and
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



